BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20043119)

  • 1. PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance.
    Escudero-Esparza A; Martin TA; Douglas-Jones A; Mansel RE; Jiang WG
    Oncol Rep; 2010 Feb; 23(2):537-44. PubMed ID: 20043119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance.
    Escudero-Esparza A; Martin TA; Davies ML; Jiang WG
    Cancer Genomics Proteomics; 2009; 6(4):239-46. PubMed ID: 19657001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placenta growth factor is over-expressed and has prognostic value in human breast cancer.
    Parr C; Watkins G; Boulton M; Cai J; Jiang WG
    Eur J Cancer; 2005 Dec; 41(18):2819-27. PubMed ID: 16275058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer.
    Maae E; Olsen DA; Steffensen KD; Jakobsen EH; Brandslund I; Sørensen FB; Jakobsen A
    Breast Cancer Res Treat; 2012 May; 133(1):257-65. PubMed ID: 22270936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.
    Cheng S; Douglas-Jones A; Yang X; Mansel RE; Jiang WG
    Cancer Genomics Proteomics; 2010; 7(2):67-73. PubMed ID: 20335520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placenta growth factor expression is correlated with survival of patients with colorectal cancer.
    Wei SC; Tsao PN; Yu SC; Shun CT; Tsai-Wu JJ; Wu CH; Su YN; Hsieh FJ; Wong JM
    Gut; 2005 May; 54(5):666-72. PubMed ID: 15831913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta growth factor expression has prognostic value in malignant pleural mesothelioma.
    Pompeo E; Albonici L; Doldo E; Orlandi A; Manzari V; Modesti A; Mineo TC
    Ann Thorac Surg; 2009 Aug; 88(2):426-31. PubMed ID: 19632388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
    Jiang WG; Douglas-Jones AG; Mansel RE
    Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.
    Parr C; Gan CH; Watkins G; Jiang WG
    Angiogenesis; 2006; 9(2):73-81. PubMed ID: 16758268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta growth factor is a survival factor for human malignant mesothelioma cells.
    Albonici L; Doldo E; Palumbo C; Orlandi A; Bei R; Pompeo E; Mineo TC; Modesti A; Manzari V
    Int J Immunopathol Pharmacol; 2009; 22(2):389-401. PubMed ID: 19505392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
    Donnini S; Machein MR; Plate KH; Weich HA
    J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.
    Jiang WG; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE; Fodstad O
    Int J Cancer; 2005 Dec; 117(5):730-7. PubMed ID: 15957166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
    Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic processing regulates placental growth factor activities.
    Hoffmann DC; Willenborg S; Koch M; Zwolanek D; Müller S; Becker AK; Metzger S; Ehrbar M; Kurschat P; Hellmich M; Hubbell JA; Eming SA
    J Biol Chem; 2013 Jun; 288(25):17976-89. PubMed ID: 23645683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer.
    Mäenpää N; Tiainen L; Hämäläinen M; Luukkaala T; Tanner M; Lahdenperä O; Vihinen P; Karihtala P; Kellokumpu-Lehtinen PL; Moilanen E; Jukkola A
    BMC Cancer; 2024 Mar; 24(1):331. PubMed ID: 38468231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer.
    Chen CN; Hsieh FJ; Cheng YM; Cheng WF; Su YN; Chang KJ; Lee PH
    Cancer Lett; 2004 Sep; 213(1):73-82. PubMed ID: 15312686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
    Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G
    Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
    Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
    Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.